BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36056935)

  • 21. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
    Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
    PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation.
    Chai J; Choudhuri J; Wang Q; Fang Y; Shi Y; Kamel J; Shah N; Sica RA; Kornblum N; Konopleva M; Mantzaris I; Shastri A; Gritsman K; Verma A; Goldfinger M; Goel S; Wang Y; Tian X
    Leuk Lymphoma; 2023 Oct; 64(10):1662-1672. PubMed ID: 37424335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between the expression of PD-L1 and
    Li J; Chen R; Chen Y; Xia Q; Zhou X; Xia Q; Wang C; Wan L; Bao H; Huang G; Liu J
    Br J Cancer; 2023 Aug; 129(3):541-550. PubMed ID: 37311977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma.
    Cui Y; Li J; Zhang P; Yin D; Wang Z; Dai J; Wang W; Zhang E; Guo R
    J Exp Clin Cancer Res; 2023 Jun; 42(1):146. PubMed ID: 37303063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity.
    Li L; Yang L; Cheng S; Fan Z; Shen Z; Xue W; Zheng Y; Li F; Wang D; Zhang K; Lian J; Wang D; Zhu Z; Zhao J; Zhang Y
    Mol Cancer; 2019 Jun; 18(1):108. PubMed ID: 31221150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-155-5p suppresses PD-L1 expression in lung adenocarcinoma.
    Huang J; Weng Q; Shi Y; Mao W; Zhao Z; Wu R; Ren J; Fang S; Lu C; Du Y; Ji J
    FEBS Open Bio; 2020 Jun; 10(6):1065-1071. PubMed ID: 32237066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 28. SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma.
    Huang Z; Chen X; Wang Y; Yuan J; Li J; Hang W; Meng H
    Front Immunol; 2024; 15():1372215. PubMed ID: 38655266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAGAP expression influences CD4+ T cell differentiation, immune infiltration, and cytotoxicity in LUAD through the STAT pathway: implications for immunotherapy.
    Xu Z; Zheng T; Zheng Z; Jiang W; Huang L; Deng K; Yuan L; Qin F; Sun Y; Qin J; Li S
    Front Immunol; 2023; 14():1224340. PubMed ID: 37744350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion.
    Zhu P; Kang G; Jiao Y; Gui C; Fan H; Li X; Jia Y; Zhang L; Ma X
    Hum Cell; 2022 Jul; 35(4):1207-1218. PubMed ID: 35593989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
    Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
    Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures.
    Sui P; Liu X; Zhong C; Sha Z
    Sci Rep; 2024 May; 14(1):10873. PubMed ID: 38740918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels.
    Lewandowski K; Kanduła Z; Gniot M; Paczkowska E; Nawrocka PM; Wojtaszewska M; Janowski M; Mariak M; Handschuh L; Kozlowski P
    Ann Hematol; 2022 Dec; 101(12):2665-2677. PubMed ID: 36266510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma.
    Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C
    Int J Biol Sci; 2020; 16(13):2271-2282. PubMed ID: 32760196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAK-STAT1 Signaling Pathway Is an Early Response to
    Li X; Pan K; Vieth M; Gerhard M; Li W; Mejías-Luque R
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456965
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.
    Sun H; Liu SY; Zhou JY; Xu JT; Zhang HK; Yan HH; Huan JJ; Dai PP; Xu CR; Su J; Guan YF; Yi X; Yu RS; Zhong WZ; Wu YL
    EBioMedicine; 2020 Oct; 60():102990. PubMed ID: 32927274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIM2 upregulation promotes metastatic progression and PD-L1 expression in lung adenocarcinoma.
    Zheng JQ; Lin CH; Lee HH; Chang WM; Li LJ; Su CY; Lee KY; Chiu HW; Lin YF
    Cancer Sci; 2023 Jan; 114(1):306-320. PubMed ID: 36104978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymol targeting interleukin 4 induced 1 expression reshapes the immune microenvironment to sensitize the immunotherapy in lung adenocarcinoma.
    Li T; Shi J; Wang L; Qin X; Zhou R; Dong M; Ren F; Li X; Zhang Z; Chen Y; Liu Y; Piao Y; Shi Y; Xu S; Chen J; Li J
    MedComm (2020); 2023 Oct; 4(5):e355. PubMed ID: 37655051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
    Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
    Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
    Seo SK; Seo DI; Park WS; Jung WK; Lee DS; Park SG; Choi JS; Kang MS; Choi YH; Choi I; Yu BC; Choi IW
    Life Sci; 2014 Sep; 112(1-2):82-9. PubMed ID: 25072357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.